19-41219403-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_021913.5(AXL):c.11G>A(p.Arg4Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000175 in 1,600,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021913.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AXL | NM_021913.5 | c.11G>A | p.Arg4Gln | missense_variant | 1/20 | ENST00000301178.9 | |
AXL | NM_001699.6 | c.11G>A | p.Arg4Gln | missense_variant | 1/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AXL | ENST00000301178.9 | c.11G>A | p.Arg4Gln | missense_variant | 1/20 | 1 | NM_021913.5 | A2 | |
AXL | ENST00000359092.7 | c.11G>A | p.Arg4Gln | missense_variant | 1/19 | 1 | P2 | ||
AXL | ENST00000599659.5 | n.25G>A | non_coding_transcript_exon_variant | 1/12 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152132Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000135 AC: 3AN: 221510Hom.: 0 AF XY: 0.00000830 AC XY: 1AN XY: 120440
GnomAD4 exome AF: 0.0000180 AC: 26AN: 1448114Hom.: 0 Cov.: 37 AF XY: 0.0000153 AC XY: 11AN XY: 719082
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152132Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.11G>A (p.R4Q) alteration is located in exon 1 (coding exon 1) of the AXL gene. This alteration results from a G to A substitution at nucleotide position 11, causing the arginine (R) at amino acid position 4 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at